Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting

Objective: This study aimed to investigate the efficacy and safety of low-dose rituximab (RTX) in the treatment of neuromyelitis optica spectrum disorders (NMOSD) patients. Methods: NMOSD patients were treated with RTX at ~25% of the standard dose. The annualized relapse rate (ARR), expanded disabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Haibing, Zeng, Wenshuang, Li, Ling, Li, Lina, Cui, Yuzhen, Wang, Jie, Ye, Jinhao, Yang, Qingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358348/
https://www.ncbi.nlm.nih.gov/pubmed/32733365
http://dx.doi.org/10.3389/fneur.2020.00642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358348/
https://www.ncbi.nlm.nih.gov/pubmed/32733365
http://dx.doi.org/10.3389/fneur.2020.00642

Ejemplares similares